Innovotech (IOT) Stock Overview
Provides assay kits used in growing microbial biofilms for research purposes in Canada, the United States, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
IOT Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
The Market Is Sleeping on This Parkinson's Biotech - And I Think That's a Mistake
Gain Therapeutics: The Under-the-Radar Biotech With Big Parkinson’s Potential Key Takeaways Gain Therapeutics (GANX) is developing GT-02287 – an oral, first-in-class, potentially disease-modifying treatment for Parkinson’s disease targeting the GCase enzyme pathway. Parkinson’s disease represents a $4 billion U.S. market with zero approved disease-modifying therapies.Read more
Innovotech Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.18 |
| 52 Week High | CA$0.34 |
| 52 Week Low | CA$0.10 |
| Beta | 1.17 |
| 1 Month Change | -18.18% |
| 3 Month Change | -35.71% |
| 1 Year Change | 28.57% |
| 3 Year Change | 20.00% |
| 5 Year Change | 12.50% |
| Change since IPO | -14.29% |
Recent News & Updates
Shareholder Returns
| IOT | CA Life Sciences | CA Market | |
|---|---|---|---|
| 7D | 2.9% | -0.1% | 2.1% |
| 1Y | 28.6% | 8.3% | 42.4% |
Return vs Industry: IOT exceeded the Canadian Life Sciences industry which returned 8.3% over the past year.
Return vs Market: IOT underperformed the Canadian Market which returned 41.9% over the past year.
Price Volatility
| IOT volatility | |
|---|---|
| IOT Average Weekly Movement | 16.2% |
| Life Sciences Industry Average Movement | 7.8% |
| Market Average Movement | 11.0% |
| 10% most volatile stocks in CA Market | 19.2% |
| 10% least volatile stocks in CA Market | 3.9% |
Stable Share Price: IOT's share price has been volatile over the past 3 months compared to the Canadian market.
Volatility Over Time: IOT's weekly volatility (16%) has been stable over the past year, but is still higher than 75% of Canadian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 16 | Craig Milne | innovotech.ca |
Innovotech Inc. provides assay kits used in growing microbial biofilms for research purposes in Canada, the United States, and internationally. The company offers InnovoSIL, a silver periodate antimicrobial compounds for medical applications; and MBEC Assay kit, a screening assay used to determine the efficacy of antimicrobials against biofilms of a variety of microorganisms; pre-coated MBEC Assay lids; and order biofilm assays. It also provides antimicrobial contract research and antimicrobial testing; antimicrobial and anti-biofilm agents; antimicrobial and anti-biofilm materials; BEST assay testing; implanted medical devices testing; bacteriophage testing; and analytical services.
Innovotech Inc. Fundamentals Summary
| IOT fundamental statistics | |
|---|---|
| Market cap | CA$9.80m |
| Earnings (TTM) | CA$94.38k |
| Revenue (TTM) | CA$4.53m |
Is IOT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| IOT income statement (TTM) | |
|---|---|
| Revenue | CA$4.53m |
| Cost of Revenue | CA$2.14m |
| Gross Profit | CA$2.40m |
| Other Expenses | CA$2.30m |
| Earnings | CA$94.38k |
Last Reported Earnings
Dec 31, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.0017 |
| Gross Margin | 52.86% |
| Net Profit Margin | 2.08% |
| Debt/Equity Ratio | 4.4% |
How did IOT perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/04/12 05:53 |
| End of Day Share Price | 2026/04/10 00:00 |
| Earnings | 2025/12/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Innovotech Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.